| Artículo | 2024 |
A phase 2, multicenter, clinical trial of CPX-351 in older patients with secondary or high-risk acute myeloid leukemia: PETHEMA-LAMVYX
|
CANCER |
| Artículo | 2024 |
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
|
NEW ENGLAND JOURNAL OF MEDICINE |
| Artículo | 2024 |
Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions
|
BRITISH JOURNAL OF CANCER |
| Revisión | 2024 |
Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations
|
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY |
| Letter | 2024 |
Comment on: Intravenous iron for critically ill children. Comparison of three dose regimens
|
PEDIATRIC BLOOD & CANCER |
| Corrección | 2024 |
Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring (Front. Immunol., (2024), 14, 1280580, 10.3389/fimmu.2023.1280580)
|
FRONTIERS IN IMMUNOLOGY |
| Artículo | 2024 |
COVID-19 in patients with haematologic malignancies: effect of RNAemia on clinical outcome in vaccinated patients.
|
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES |
| Artículo | 2024 |
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?
|
ANNALS OF HEMATOLOGY |
| Artículo | 2024 |
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update
|
BLOOD |
| Artículo | 2024 |
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry
|
CANCER |
| Artículo | 2024 |
Genital chronic graft-versus-host disease: an unmet need that requires trained gynecologists
|
CLIMACTERIC |
| Artículo | 2024 |
Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study
|
LANCET HAEMATOLOGY |
| Artículo | 2024 |
Incorporation mutational profile might reduce the importance of blast count in prognostication of low-risk myelodysplastic syndromes
|
BRITISH JOURNAL OF HAEMATOLOGY |
| Letter | 2024 |
Monocytosis as prognostic factor for chronic graft versus host disease
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2024 |
Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell features
|
CELLULAR ONCOLOGY |
| Artículo | 2024 |
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry
|
HAEMATOLOGICA |
| Artículo | 2024 |
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
|
Transplantation and Cellular Therapy |
| Artículo | 2024 |
PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT
|
Blood Advances |
| Letter | 2024 |
Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT
|
BONE MARROW TRANSPLANTATION |
| Letter | 2024 |
Standardized translations of the Lee Chronic GvHD Symptom Scale to 12 European languages: an EU COST Action cGvHD Eurograft project
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2024 |
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
|
BONE MARROW TRANSPLANTATION |
| Corrección | 2024 |
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT (Mar, 10.1038/s41409-024-02269-4, 2024)
|
BONE MARROW TRANSPLANTATION |
| Letter | 2024 |
Validation of mutated CEBPA bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registry
|
HAEMATOLOGICA |
| Ponencia | 2023 |
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023
|
HEMATOLOGICAL ONCOLOGY |
| Ponencia | 2023 |
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023
|
HEMATOLOGICAL ONCOLOGY |
| Artículo | 2023 |
A phase II, prospective, randomized, open-label study of defibrotide added to standard-of-care prophylaxis for the prevention of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation
|
HAEMATOLOGICA |
| Artículo | 2023 |
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells
|
HAEMATOLOGICA |
| Artículo | 2023 |
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group
|
BLOOD CANCER JOURNAL |
| Artículo | 2023 |
ECP versus ruxolitinib in steroid-refractory acute GVHD – a retrospective study by the EBMT transplant complications working party
|
FRONTIERS IN IMMUNOLOGY |
| Editorial | 2023 |
Editorial: Regulatory T cells in graft versus host disease.
|
FRONTIERS IN IMMUNOLOGY |
| Artículo | 2023 |
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
|
BONE MARROW TRANSPLANTATION |
| Letter | 2023 |
Ferric Carboxymaltose in Heart Failure with Iron Deficiency
|
NEW ENGLAND JOURNAL OF MEDICINE |
| Artículo | 2023 |
First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia
|
Clinical and Translational Science |
| Artículo | 2023 |
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study
|
LANCET ONCOLOGY |
| Artículo | 2023 |
Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1- stem cell-like T cells over PD-1+ T cells curbing tumor progression
|
FRONTIERS IN IMMUNOLOGY |
| Artículo | 2023 |
Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring
|
FRONTIERS IN IMMUNOLOGY |
| Artículo | 2023 |
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia
|
Blood Advances |
| Artículo | 2023 |
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors
|
FRONTIERS IN IMMUNOLOGY |
| Artículo | 2023 |
Molecular landscape and validation of new genomic classification in 2668 adult AML patients: real life data from the PETHEMA registry
|
CANCERS |
| Artículo | 2023 |
Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies
|
FRONTIERS IN IMMUNOLOGY |
| Artículo | 2023 |
Prognostic value of measurable residual disease in patients with AML undergoing HSCT: a multicenter study
|
CANCERS |
| Letter | 2023 |
Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
|
BONE MARROW TRANSPLANTATION |
| Letter | 2023 |
Successful use of thrombopoietin analogs in thrombocytopenia associated with MYH-9 mutation
|
ANNALS OF HEMATOLOGY |
| Artículo | 2023 |
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials.
|
CLINICAL CANCER RESEARCH |
| Artículo | 2022 |
Acute leukemia arising from myeloproliferative or myelodysplastic/myeloproliferative neoplasms: A series of 372 patients from the PETHEMA AML registry
|
LEUKEMIA RESEARCH |
| Artículo | 2022 |
CD4+ and CD8+ T-cell responses in bone marrow to fatty acids in high-fat diets
|
JOURNAL OF NUTRITIONAL BIOCHEMISTRY |
| Artículo | 2022 |
Cholinergic signals preserve haematopoietic stem cell quiescence during regenerative haematopoiesis
|
NATURE COMMUNICATIONS |
| Artículo | 2022 |
Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib.
|
Scientific reports |
| Artículo | 2022 |
Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT
|
BLOOD CANCER JOURNAL |
| Artículo | 2022 |
Differential engraftment of parental A20 PD-L1 WT and PD-L1 KO leukemia cells in semiallogeneic recipients in the context of PD-L1/PD-1 interaction and NK cell-mediated hybrid resistance
|
FRONTIERS IN IMMUNOLOGY |
| Artículo | 2022 |
Effect of vitamin D on graft-versus-host disease
|
Biomedicines |
| Artículo | 2022 |
Impact of FLT3–ITD mutation status and its ratio in a cohort of 2901 patients undergoing upfront intensive chemotherapy: a PETHEMA registry study
|
CANCERS |
| Artículo | 2022 |
Mesenchymal Stromal Cells for Treating Steroid-Resistant Acute and Chronic Graft Versus Host Disease: A Multicenter Compassionate Use Experience
|
STEM CELLS TRANSLATIONAL MEDICINE |
| Artículo | 2022 |
Phase I/II clinical trials of donor-derived purified regulatory T cells for the treatment of steroid-refractory chronic graft versus host disease
|
BLOOD |
| Artículo | 2022 |
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment
|
Transplantation and Cellular Therapy |
| Corrección | 2022 |
Publisher correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab (Leukemia, (2021), 35, 1, (201-214), 10.1038/s41375-020-0840-y)
|
LEUKEMIA |
| Artículo | 2022 |
SF3B1, RUNX1 and TP53 mutations significantly impact the outcome of patients with lower-risk myelodysplastic syndrome
|
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
| Revisión | 2022 |
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients
|
LEUKEMIA & LYMPHOMA |
| Artículo | 2022 |
The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejection
|
TRANSLATIONAL RESEARCH |
| Artículo | 2022 |
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|
NATURE MEDICINE |
| Artículo | 2021 |
Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2021 |
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
|
ANNALS OF HEMATOLOGY |
| Corrección | 2021 |
Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial (Annals of Hematology, (2021), 100, 5, (1181-1194), 10.1007/s00277-021-04465-4)
|
ANNALS OF HEMATOLOGY |
| Revisión | 2021 |
Current Status of CAR-T Cell Therapy in Multiple Myeloma
|
Hemato |
| Artículo | 2021 |
Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease.
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2021 |
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?
|
LEUKEMIA |
| Revisión | 2021 |
Graft-versus-host disease prophylaxis: pathophysiology-based review on current approaches and future directions
|
Blood Reviews |
| Artículo | 2021 |
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia
|
LEUKEMIA |
| Artículo | 2021 |
Long-term impact of an educational antimicrobial stewardship program on management of patients with hematological diseases
|
Antibiotics |
| Artículo | 2021 |
Long-term outcomes after autologous versus allogeneic stem cell transplantation in molecularly-stratified patients with intermediate cytogenetic risk acute myeloid leukemia: a PETHEMA study
|
Transplantation and Cellular Therapy |
| Artículo | 2021 |
MUFAs in high-fat diets protect against obesity-induced bias of hematopoietic cell lineages
|
MOLECULAR NUTRITION & FOOD RESEARCH |
| Artículo | 2021 |
Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMT
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2021 |
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
|
HAEMATOLOGICA |
| Letter | 2021 |
Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors
|
BONE MARROW TRANSPLANTATION |
| Letter | 2021 |
T-cells immune response controls the high incidence of adenovirus infection in adult allogenic hematopoietic transplantation recipients
|
HAEMATOLOGICA |
| Artículo | 2021 |
Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2021 |
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
|
LEUKEMIA |
| Artículo | 2020 |
ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype
|
CANCER MEDICINE |
| Artículo | 2020 |
Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
| Corrección | 2020 |
Corrigendum to “Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study” [Leuk. Res. 92 (March) (2020) 106352] (Leukemia Research (2020) 92, (S0145212620300576), (10.1016/j.leukres.2020.106352))
|
LEUKEMIA RESEARCH |
| Artículo | 2020 |
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model
|
Cancer Immunology, Immunotherapy |
| Artículo | 2020 |
Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2020 |
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia
|
JOURNAL OF CLINICAL ONCOLOGY |
| Artículo | 2020 |
Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2020 |
Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation
|
BONE MARROW TRANSPLANTATION |
| Revisión | 2020 |
Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma
|
FRONTIERS IN IMMUNOLOGY |
| Artículo | 2020 |
Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study
|
LEUKEMIA RESEARCH |
| Artículo | 2020 |
Polyphenolic extract (PE) from olive oil exerts a potent immunomodulatory effect and prevents graft-versus-host disease in a mouse model
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2020 |
Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease
|
NEW ENGLAND JOURNAL OF MEDICINE |
| Artículo | 2020 |
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study
|
BONE MARROW TRANSPLANTATION |
| Revisión | 2020 |
The role of TNFR2 and DR3 in the in vivo expansion of tregs in t cell depleting transplantation regimens
|
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| Artículo | 2019 |
A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients
|
LEUKEMIA RESEARCH |
| Artículo | 2019 |
Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant Approval
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2019 |
Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes
|
BLOOD |
| Artículo | 2019 |
Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH)
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
| Artículo | 2019 |
Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists
|
INVESTIGATIONAL NEW DRUGS |
| Letter | 2019 |
HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT
|
CELLULAR & MOLECULAR IMMUNOLOGY |
| Resumen congreso | 2019 |
Influence of basic parameters of hemostasis in the hemorrhagic profile of the chronic PTI
|
HAEMATOLOGICA |
| Resumen congreso | 2019 |
Mutational profile in patients with low-risk myelodysplastic syndrome at the time of progression to acute leukemia
|
HAEMATOLOGICA |
| Artículo | 2019 |
Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Resumen congreso | 2019 |
Sequential cumulative effect on the alfa diversity of the intestinal microbiota of honey-binding conditions and active antibiotics against gram-negatives
|
HAEMATOLOGICA |
| Artículo | 2019 |
Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms
|
CLINICAL CANCER RESEARCH |
| Artículo | 2018 |
A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia
|
ANNALS OF HEMATOLOGY |
| Corrección | 2018 |
A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia (vol 97, pg 763, 2018)
|
ANNALS OF HEMATOLOGY |
| Letter | 2018 |
Clinical association of anti-glutathione S-transferase T1 antibodies and de novo immune hepatitis after hematopoietic cell transplantation
|
DIGESTIVE AND LIVER DISEASE |
| Artículo | 2018 |
De novo recipient-specific Glutathione S-transferase T1 antibody development after HLA-identical hematopoietic cell transplantation
|
Transplant Immunology |
| Resumen congreso | 2018 |
European Myeloma Network phase I trial on RIC allogeneic transplantation: an optimized program for high risk relapsed myeloma patients
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2018 |
Evaluation of parameters related to the probability of leukemic progression in patients with lower-risk myelodysplastic syndrome
|
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
| Resumen congreso | 2018 |
FOUR CASES OF MYELOID NEOPLASM RELATED TO THERAPEUTICS IN THE CONTEXT OF TREATMENT OF SARCOMAS IN FLABBY PARTS
|
HAEMATOLOGICA |
| Artículo | 2018 |
Genotoxicity of tetrahydrofolic acid to hematopoietic stem and progenitor cells
|
CELL DEATH AND DIFFERENTIATION |
| Resumen congreso | 2018 |
IBRUTINIB - RELATED TOXICITY AND SUSPENSION OF TREATMENT
|
HAEMATOLOGICA |
| Artículo | 2018 |
IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q-AML
|
ONCOIMMUNOLOGY |
| Letter | 2018 |
KIT D816V-chronic myelomonocytic leukemia progressing to KIT D816V+associated to mast cell leukemia responding to allogeneic hematopoietic cell transplantation
|
ANNALS OF HEMATOLOGY |
| Artículo | 2018 |
Noninvasive prenatal diagnosis by cell-free DNA screening for fetomaternal HPA-1a platelet incompatibility
|
TRANSFUSION |
| Artículo | 2018 |
PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation
|
ANNALS OF HEMATOLOGY |
| Artículo | 2018 |
Plataforma para la extracción automática y codificación de conceptos dentro del ámbito de la Oncohematología (Proyecto COCO)
|
PROCESAMIENTO DEL LENGUAJE NATURAL |
| Resumen congreso | 2018 |
Pre-clinical trial to evaluate the effectiveness of ixazomib as a prophylaxis of sickness disease against guest (chronic eich) in a murine model
|
HAEMATOLOGICA |
| Resumen congreso | 2018 |
Pre-Clinical Trial to Evaluate the Efficacy of Delayed Administration of Ixazomib in the Prophylaxis of Chronic Graft-Versus-Host Disease
|
BLOOD |
| Resumen congreso | 2018 |
Prognostic value of minimal residual disease before allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia
|
BLOOD |
| Resumen congreso | 2018 |
PROGNOSTIC VALUE OF PRE-ALOTPH EMR IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA
|
HAEMATOLOGICA |
| Resumen congreso | 2018 |
RATIO OF ABSOLUTE CIRCULATING LYMPHOCYTES/MONOCYTES AS A PROGNOSTIC FACTOR IN THE DLCL-B TO DIAGNOSIS
|
HAEMATOLOGICA |
| Artículo | 2018 |
Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting
|
MEDICAL ONCOLOGY |
| Resumen congreso | 2018 |
RESULTS OF TREATMENT GUIDED BY PET/INTERMEDIATE TAC IN PATIENTS WITH DIAGNOSIS OF LYMPHOMA B DIFFUSE OF LARGE CELLS (LBDCG). EXPERIENCE OF A CENTER
|
HAEMATOLOGICA |
| Artículo | 2018 |
RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation
|
CELL DEATH & DISEASE |
| Artículo | 2018 |
Selection of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients Through the Identification of T-Cells Capable to Establish Stable Interactions With the Leukemic Cells: "Doublet Technology"
|
FRONTIERS IN IMMUNOLOGY |
| Artículo | 2018 |
Therapeutic implications of NK cell regulation of allogeneic CD8 T cell-mediated immune responses stimulated through the direct pathway of antigen presentation in transplantation
|
MABS |
| Resumen congreso | 2018 |
USE OF SORAFENIB IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA FLT3-ITD POSITIVE IN SITUATION OF RELAPSE OR REFRACTORINESS: RECENT EXPERIENCE OF A CENTER
|
HAEMATOLOGICA |
| Revisión | 2018 |
Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications
|
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| Resumen congreso | 2018 |
WHAT CAN WE CONCLUDE FROM RUXOLITINIB AFTER MORE THAN 5 YEARS OF EXPERIENCE WITH THE DRUG?
|
HAEMATOLOGICA |
| Resumen congreso | 2017 |
ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE, EXPERIENCE IN A SINGLE CENTER
|
HAEMATOLOGICA |
| Resumen congreso | 2017 |
ANAGRELIDE RESPONSE ACCORDING TO THE MOLECULAR PROFILE: SOMETHING TO CONCLUDE ON THE MECHANISM OF ACTION OF THE DRUG IN MYELOPROLIFERATIVE NEOPLASMS (MPN)?
|
HAEMATOLOGICA |
| Resumen congreso | 2017 |
ANALYSIS OF PROGNOSTIC FACTORS IN PATIENTS WITH MYELODISPLASIC SYNDROME SUBJECTED TO ALOGENIC TRANSPLANT OF HEMATOPOYETIC PROGENITORS
|
HAEMATOLOGICA |
| Resumen congreso | 2017 |
Analysis of the incidence and causes of admission in the icu in large cohort of adult patients subjected to hematopoyetic transplantation
|
HAEMATOLOGICA |
| Resumen congreso | 2017 |
ASSESSING PROGNOSIS IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES. PARAMETERS RELATED TO THE PROBABILITY OF LEUKEMIC PROGRESSION
|
LEUKEMIA RESEARCH |
| Letter | 2017 |
Candida parapsilosis misleading the automated absolute and differential white blood cell count
|
ANNALS OF HEMATOLOGY |
| Artículo | 2017 |
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo
|
INTERNATIONAL JOURNAL OF CANCER |
| Resumen congreso | 2017 |
COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF EXTRACORPOREAL PHOTOPHERESIS AS A RESCUE TREATMENT OF THE CHRONIC EICR ACCORDING TO OPEN OR CLOSED SYSTEM: EXPERIENCE OF TWO CENTERS
|
HAEMATOLOGICA |
| Artículo | 2017 |
Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis
|
EXPERIMENTAL HEMATOLGY & ONCOLOGY |
| Resumen congreso | 2017 |
Description of Mutational Profile in Patients with Lower-Risk Myelodysplastic Syndromes at the Time of Leukemic Progression
|
BLOOD |
| Resumen congreso | 2017 |
DISCONTINUING ANTIBACTERIAL THERAPY AFTER APYREXIA AND CLINICAL STABILITY REGARDLESS OF NEUTROPHIL COUNT IN FEBRIL NEUTROPENIA IS SAFE AND REDUCES EXPOSITION TO ANTIBIOTICS (HOWLONG RANDOMIZED TRIAL)
|
HAEMATOLOGICA |
| Artículo | 2017 |
Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Resumen congreso | 2017 |
EUROPEAN MYELOMA NETWORK CLINICAL TRIAL PHASE I (ALLO-EMN) OF ALLOGENIC TRANSPLANTATION IN PATIENTS WITH HIGH RISK MULTIPLE MYELOMA (MM)
|
HAEMATOLOGICA |
| Resumen congreso | 2017 |
Improvement of outcome after autologous stem cell transplantation by reduction of infections and SOS/VOD syndrome's related mortality: 28 years single-center experience
|
BONE MARROW TRANSPLANTATION |
| Letter | 2017 |
Intravascular lymphoma: look through the small vessels
|
ANNALS OF HEMATOLOGY |
| Resumen congreso | 2017 |
Is idiopathic myelofibrosis (MFI) with V617 JAK2 mutation is the same entity as secondary myelofibrosis (MFS) to evolution of mutated myeloproliferative neoplasm (MPN)?
|
HAEMATOLOGICA |
| Artículo | 2017 |
Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier
|
TRANSLATIONAL RESEARCH |
| Resumen congreso | 2017 |
MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS AND TRANSPLANT RECIPIENTS OF HEMATOPOIETIC PROGENITORS
|
HAEMATOLOGICA |
| Resumen congreso | 2017 |
MULTICENTRIC STUDY ON THE USE OF RUXOLITINIB IN ACUTE AND REFRACTORY CHRONIC EICH IN ONE OR MORE TREATMENT LINES. RESULTS OF OUR EXPERIENCE
|
HAEMATOLOGICA |
| Artículo | 2017 |
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial
|
LANCET HAEMATOLOGY |
| Letter | 2017 |
Panobinostat induces CD38 upregulation and augments the antimyeloma efficacy of daratumumab
|
BLOOD |
| Resumen congreso | 2017 |
POLYGLOBULIA IN THE YOUNG MAN IN THE AGE OF HEALTH CONTROLS: NEED FOR NEW PHYSIOLOGICAL RANGES OR EXCEPTION TO THE WHO 2016 CLASSIFICATION?
|
HAEMATOLOGICA |
| Resumen congreso | 2017 |
Prognostic evaluation in patients with low risk myelodysplastic syndrome parameters related to the probability of leukemic progression
|
HAEMATOLOGICA |
| Artículo | 2017 |
RUNX1 amplification in AML with myelodysplasia-related changes and ring 21 chromosomes
|
HEMATOLOGICAL ONCOLOGY |
| Resumen congreso | 2017 |
Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study
|
BLOOD |
| Resumen congreso | 2017 |
Similar Probabilities of Failure to Reach Transplantation and Transplant Outcomes after HLA-Identical Sibling or Unrelated Donor Transplant in Patients with Acute Myeloid Leukemia: A Single Institution Evaluation of a Donor Selection Algorithm
|
BLOOD |
| Artículo | 2017 |
Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation
|
BONE MARROW TRANSPLANTATION |
| Resumen congreso | 2017 |
THE 1RC STATUS AND THE NEW DIAGNOSIS ARE ASSOCIATED WITH BETTER LONG-TERM SURVIVAL IN ALLOTRANSPLANTED PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA
|
HAEMATOLOGICA |
| Resumen congreso | 2017 |
THE COMBINED TREATMENT WITH AAS AND HEPARIN OF LOW MOLECULAR WEIGHT IS EFFECTIVE IN THE PREVENTION OF THROMBOSIS IN PREGNANT WOMEN WITH MYELOPROLIFERATIVE NEOPLASMS
|
HAEMATOLOGICA |
| Artículo | 2017 |
The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome
|
LEUKEMIA & LYMPHOMA |
| Resumen congreso | 2017 |
THE PROBABILITY OF CONCLUDING ALLOGENIC TRANSPLANTATION FROM ITS INDICATION IS SIMILAR TO HAVING OR NOT HAVING HISTOCOMPATIBLE SIBLING: SELECTION STRATEGY BASED ON THE PREFERENTIAL USE OF UNRELATED DONOR (ND) AS AN ALTERNATIVE SOURCE OF HAEMATOPOIETIC PROGENITORS (HP)
|
HAEMATOLOGICA |
| Resumen congreso | 2017 |
TO SUSPEND THE EMPIRICAL ANTIMICROBIAL TREATMENT AFTER THREE DAYS OF APYREXIA IN HEMATOLOGICAL PATIENTS WITH FEBRILE NEUTROPENIA IS SAFE AND REDUCES UNNECESSARY EXPOSURE TO ANTIBIOTICS: FINAL RESULTS OF THE RANDOMIZED CLINICAL TRIAL HOW LONG
|
HAEMATOLOGICA |
| Artículo | 2017 |
Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meeting
|
LEUKEMIA & LYMPHOMA |
| Resumen congreso | 2017 |
Xenografts of blasts originating from patients with acute myeloblastic leukemia in immunosuppressed mice: clinical implications potentials
|
HAEMATOLOGICA |
| Resumen congreso | 2016 |
Cannabinoids Derivatives Exert a Potent Antileukemic Effect By Modifying the Pattern of Membrane Sphingolipids
|
BLOOD |
| Artículo | 2016 |
Caspase-8 inhibition represses initial human monocyte activation in septic shock model
|
ONCOTARGET |
| Artículo | 2016 |
Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Letter | 2016 |
GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2016 |
Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis
|
BLOOD |
| Artículo | 2016 |
Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial
|
CLINICAL CANCER RESEARCH |
| Artículo | 2016 |
Immunotherapeutic targeting of LIGHT/LT beta R/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells
|
MABS |
| Artículo | 2016 |
Methionine synthase reductase deficiency (CblE): A report of two patients and a novel mutation
|
Hematology |
| Artículo | 2016 |
NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression
|
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY |
| Letter | 2016 |
Pre-transplant diastolic but not systolic dysfunction has a negative prognostic impact after allogeneic stem cell transplantation
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2016 |
Sensitivity of hematopoietic stem cells to mitochondrial dysfunction by SdhD gene deletion
|
CELL DEATH & DISEASE |
| Artículo | 2016 |
Strong periodic acid-schiff reaction in hypervacuolated blastic plasmacytoid dendritic cell neoplasm
|
DIAGNOSTIC CYTOPATHOLOGY |
| Resumen congreso | 2016 |
Survival and long-term complications of receptors of hematopoietic progenitor transplantation
|
HAEMATOLOGICA |
| Artículo | 2016 |
The Dynamics of the Human Leukocyte Antigen Head Domain Modulates Its Recognition by the T-Cell Receptor
|
PLOS ONE |
| Resumen congreso | 2016 |
THE INCORPORATION OF COMORBIDITIES IN THE PROGNOSTICATION OF PATIENTS WITH LOWER-RISK MDS
|
HAEMATOLOGICA |
| Resumen congreso | 2015 |
After admission to intensive care unit non-transplant patients with haematologic malignancies have better survival outcome than recipients of haematopoietic stem cell transplantation
|
HAEMATOLOGICA |
| Editorial | 2015 |
Anti-common gamma-chain antibody: one for all in GVHD
|
BLOOD |
| Artículo | 2015 |
Black Bone Marrow Variable Cytoplasmic Melanin Content in Malignant Melanoma Cells in Bone Marrow Aspirate
|
DIAGNOSTIC CYTOPATHOLOGY |
| Editorial | 2015 |
Bone marrow cellular cannibalism by medulloblastoma
|
AMERICAN JOURNAL OF HEMATOLOGY |
| Resumen congreso | 2015 |
Characteristics of oncohematological patients admitted in the intensive care unit (uci): comparision between the patients subjected to transplant of hematopoietic progenitors and non transplantation (no-tph)
|
HAEMATOLOGICA |
| Artículo | 2015 |
Emerging BCR/ABL1 Mutations Under Treatment with Tyrosine Kinase inhibitors in Paediatric Acute Lymphoblastic Leukaemia
|
ACTA HAEMATOLOGICA |
| Artículo | 2015 |
Evaluation of a method for murine monocyte isolation by bone marrow depletion
|
ANALYTICAL BIOCHEMISTRY |
| Artículo | 2015 |
GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2015 |
Human Bone Marrow Stromal Cells Differentiate Into Corneal Tissue and Prevent Ocular Graft-Versus-Host Disease in Mice
|
Cell Transplantation |
| Resumen congreso | 2015 |
IMPLICATIONES OF THE ADVERSE KARYOTYPE IN PATIENTS WITH MYELODYSPPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA. EXPERIENCE OF A CENTRE
|
HAEMATOLOGICA |
| Artículo | 2015 |
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2015 |
Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure
|
TRANSFUSION |
| Resumen congreso | 2015 |
MISMATCH ON GLUTATHIONE S-TRANSFERASE T1 INCREASES THE RISK OF GRAFT-VERSUS-HOST DISEASE AND MORTALITY AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
|
TISSUE ANTIGENS |
| Resumen congreso | 2015 |
MUCORMYCOSIS IN ONCOHAEMATOLOGICAL PATIENTS AND RECEPTORS OF TRASPLANTS OF HAEMOTOPOIETIC PROGENITORS. EXPERIENCE OF THE LAST 10 YEARS OF A SINGLE CENTRE
|
HAEMATOLOGICA |
| Artículo | 2015 |
Multiple Pseudo-Chediak-Higashi Inclusions Associated with MYC Deletion in a Patient with Acute Myeloid Leukemia
|
ACTA HAEMATOLOGICA |
| Artículo | 2015 |
Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score
|
LEUKEMIA RESEARCH |
| Letter | 2015 |
Myelodysplastic syndromes and acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) abnormality
|
MEDICINA CLINICA |
| Artículo | 2015 |
Myelomatous plasma cells display an aberrant gene expression pattern similar to that observed in normal memory B cells
|
American Journal of Cancer Research |
| Artículo | 2015 |
Overexpression of GYS1, MIF, and MYC Is Associated With Adverse Outcome and Poor Response to Azacitidine in Myelodysplastic Syndromes and Acute Myeloid Leukemia
|
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
| Artículo | 2015 |
Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study
|
HAEMATOLOGICA |
| Resumen congreso | 2015 |
Prognostic Impact of Adverse Karyotype and Treatment in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia
|
BLOOD |
| Resumen congreso | 2015 |
PROGNOSTIC VALUE OF THE EVALUATION OF THE PRETRANSPLANT ALLOGENEIC CARDIAC FUNCTION
|
HAEMATOLOGICA |
| Resumen congreso | 2015 |
Pronostic Value of Pretransplant Echocardiography in Allogeneic Hematopoietic Cell Transplantation
|
BLOOD |
| Artículo | 2015 |
PTPN13 and beta-Catenin Regulate the Quiescence of Hematopoietic Stem Cells and Their Interaction with the Bone Marrow Niche
|
STEM CELL REPORTS |
| Artículo | 2015 |
Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
| Artículo | 2015 |
Role of 18F-FDG-PET/CT in the management of marginal zone B cell lymphoma
|
HEMATOLOGICAL ONCOLOGY |
| Resumen congreso | 2015 |
THE ADDITION OF COMORBIDITY ALLOWS A BETTER STRATIFICATION AND DEVELOPMENT OF A SPECIFIC PROGNOSTIC SCORE IN THE GROUP OF PATIENTS WITH MYELODYSPLASTIC SYNDROME OF LOW RISK BY IPSS
|
HAEMATOLOGICA |
| Artículo | 2015 |
The CD27(+) memory B cells display changes in the gene expression pattern in elderly individuals
|
IMMUNOLOGY |
| Resumen congreso | 2015 |
THE INVASIVE FUNGAL INFECTION IS A CLINICALLY RELEVANT CAUSE OF MORTALITY AND MORBIDITY IN PATIENTS WITH LYMPHOPROLIFERATIVE SYNDROMES
|
HAEMATOLOGICA |
| Artículo | 2014 |
A Conditional Mouse Mutant in the Tumor Suppressor SdhD Gene Unveils a Link between p21(WAF1/Cip1) Induction and Mitochondrial Dysfunction
|
PLOS ONE |
| Artículo | 2014 |
An Active Isodicentric X Chromosome in a Case of Refractory Anaemia with Ring Sideroblasts Associated with Marked Thrombocytosis
|
Case Reports in Genetics |
| Resumen congreso | 2014 |
AZACITIDINE IMPROVES SURVIVAL IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES WITH 20-30% BONE MARROW BLASTS AND POOR-RISK CYTOGENETIC CATEGOR
|
HAEMATOLOGICA |
| Artículo | 2014 |
Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation Score Allows a Better Stratification of High-Risk Patients Undergoing Reduced-Toxicity Allogeneic Hematopoietic Cell Transplantation
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2014 |
Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphoma
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
| Artículo | 2014 |
Gene and miRNA Expression Profiles of Hematopoietic Progenitor Cells Vary Depending on Their Origin
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2014 |
Granulocyte colony-stimulating factor produces long-term changes in gene and microRNA expression profiles in CD34(+) cells from healthy donors
|
HAEMATOLOGICA |
| Artículo | 2014 |
Mismatch on Glutathione S-Transferase T1 Increases the Risk of Graft-versus-Host Disease and Mortality after Allogeneic Stem Cell Transplantation
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2014 |
Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal Prophylaxis
|
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
| Artículo | 2014 |
Pharmacological Profiles of Acute Myeloid Leukemia Treatments in Patient Samples by Automated Flow Cytometry: A Bridge to Individualized Medicine
|
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
| Artículo | 2014 |
PTPN13 regulates cellular signalling and beta-catenin function during megakaryocytic differentiation
|
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH |
| Artículo | 2014 |
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus
|
BONE MARROW TRANSPLANTATION |
| Resumen congreso | 2014 |
Role of PET/CT Assesment before Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma Patients
|
BLOOD |
| Artículo | 2014 |
Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Editorial | 2014 |
Severe hemophagocytosis syndrome: macrophage cannibalism
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
| Resumen congreso | 2013 |
Azacitidine Alone Or The Combination With Valproic Acid As a Bridge Therapy For Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes Before Transplantation
|
BLOOD |
| Artículo | 2013 |
Clinical Prognostic Factors for Survival and Risk of Progression to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndromes With < 10% Marrow Blasts and Non-Unfavorable Cytogenetic Categories
|
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
| Artículo | 2013 |
Differential cytogenetic profile in advanced chronic myeloid leukemia with sequential lymphoblastic and myeloblastic blast crisis
|
Leukemia Research Reports |
| Resumen congreso | 2013 |
EARLY DETECTION OF SERUM GALACTOMANNAN ANTIGEN IN HEMATOLOGIC MALIGNANCIES: IMPACT OF A LABORATORY ASSAY IN ASPERGILLUS INFECTION MORTALITY RATE
|
HAEMATOLOGICA |
| Póster | 2013 |
Elaboración de un kit de separación magnética de células CD3+
|
Biosaia |
| Resumen congreso | 2013 |
Fludarabine, Cyclophosphamide and Rituximab As First Line Treatment In Follicular Lymphoma
|
BLOOD |
| Resumen congreso | 2013 |
GSTT1 mismatch constitutes a risk factor for acute and chronic hepatic GVHD and influences patient survival
|
BONE MARROW TRANSPLANTATION |
| Resumen congreso | 2013 |
Higher-risk myelodysplastic syndromes. Does the severity of cytopenias at diagnosis have any prognostic significance?
|
LEUKEMIA RESEARCH |
| Artículo | 2013 |
Impact of Hyperferritinemia on the Outcome of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2013 |
Improvement over the years of long-term survival in high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy
|
TRANSPLANTATION PROCEEDINGS |
| Artículo | 2013 |
In Vitro Simulation of Corneal Epithelium Microenvironment Induces a Corneal Epithelial-like Cell Phenotype from Human Adipose Tissue Mesenchymal Stem Cells
|
CURRENT EYE RESEARCH |
| Artículo | 2013 |
Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2013 |
Lenograstim compared to filgrastim for the mobilization of hematopoietic stem cells in healthy donors
|
TRANSFUSION |
| Revisión | 2013 |
LIGHT/HVEM/LTR Interaction as a Target for the Modulation of the Allogeneic Immune Response in Transplantation
|
AMERICAN JOURNAL OF TRANSPLANTATION |
| Resumen congreso | 2013 |
Memory B Cells Display Changes In The Expression Pattern Of Genes Related To Cell Survival In Elderly Individuals
|
BLOOD |
| Resumen congreso | 2013 |
Mobilization Scheme With Cytarabine In Poor Mobilizers Patients Diagnosed With Lymphoma
|
BLOOD |
| Resumen congreso | 2013 |
Multivariable Time-Dependent Analysis Of The Impact Of 5 Azacitidine In Patients With Lower-Risk Myelodysplastic Syndrome and Unfavorable Specific Lower-Risk Score
|
BLOOD |
| Resumen congreso | 2013 |
Myelomatous Plasma Cells Display An Intermediate Gene Expression Pattern Between a Normal Plasma Cell and a Memory B Cell
|
BLOOD |
| Resumen congreso | 2013 |
Patterns of infection in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) receiving 5-azacitidine. Candidates for antifungal prophylaxis
|
LEUKEMIA RESEARCH |
| Letter | 2013 |
Pentostatin plus cyclophosphamide and bexarotene is an effective and safe combination in patients with mycosis fungoides/sezary syndrome
|
BRITISH JOURNAL OF HAEMATOLOGY |
| Artículo | 2013 |
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients
|
BRITISH JOURNAL OF HAEMATOLOGY |
| Artículo | 2013 |
The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate
|
HAEMATOLOGICA |
| Artículo | 2013 |
To freeze or not to freeze peripheral blood stem cells prior to allogeneic transplantation from matched related donors
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
| Artículo | 2013 |
Uptake and delivery of antigens by mesenchymal stromal cells
|
CYTOTHERAPY |
| Artículo | 2012 |
Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation
|
TRANSFUSION |
| Resumen congreso | 2012 |
Clinical prognostic factors for myelodysplastic syndromes presenting non-unfavourable cytogenetic categories according to IPSS and the new cytogenetic prognostic scoring system
|
HAEMATOLOGICA |
| Artículo | 2012 |
Development of a Population-Based Cost-Effectiveness Model of Chronic Graft-Versus-Host Disease in Spain
|
CLINICAL THERAPEUTICS |
| Artículo | 2012 |
Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment
|
LEUKEMIA RESEARCH |
| Artículo | 2012 |
Evaluation of prognostic factors among patients with chronic graft-versus-host disease
|
HAEMATOLOGICA |
| Resumen congreso | 2012 |
Impact of V617F mutation in the management of thrombotic risk in patients with essential thrombocytemia
|
HAEMATOLOGICA |
| Artículo | 2012 |
Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning
|
BONE MARROW TRANSPLANTATION |
| Resumen congreso | 2012 |
Increased Gene Expression Involved in Angiogenesis, Metabolism and Cell Proliferation in Acute Myeloid Leukemia and myelodysplastic Syndromes Correlates with Adverse Clinical and Biological Features
|
BLOOD |
| Resumen congreso | 2012 |
Patterns of Infection in Patients with Myeloid Malignancies Receiving 5-Azacytidine: identification of Candidates for Antifungal Prophylaxis
|
BLOOD |
| Artículo | 2012 |
Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: Results in clinical benefits and cost saving
|
CLINICA CHIMICA ACTA |
| Artículo | 2012 |
The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation
|
HAEMATOLOGICA |
| Resumen congreso | 2012 |
To freeze or not to freeze haematopoietic stem cells prior to allogeneic transplantation
|
BONE MARROW TRANSPLANTATION |
| Letter | 2011 |
Allogeneic Hematopoietic Stem-Cell Transplantation for Myeloma: It's Time for the Appropriate Studies Reply
|
JOURNAL OF CLINICAL ONCOLOGY |
| Artículo | 2011 |
B- and T-Lymphocyte Attenuator Targeting Protects Against the Acute Phase of Graft Versus Host Reaction by Inhibiting Donor Anti-Host Cytotoxicity
|
TRANSPLANTATION |
| Artículo | 2011 |
Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens
|
LEUKEMIA RESEARCH |
| Letter | 2011 |
Drug rash with eosinophilia and systemic symptoms (DRESS) after an unrelated donor BM transplant
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2011 |
Dry Eye Disease in Chronic Graft-Versus-Host Disease: Results From a Spanish Retrospective Cohort Study
|
TRANSPLANTATION PROCEEDINGS |
| Letter | 2011 |
Effect of vitamin D treatment in chronic GVHD
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2011 |
Helicobacter pylori Infection and Graft-versus-Host Disease
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2011 |
Influence of glutathione S-transferase T1 donor/recipient mismatch and anti-GSTT1 antibodies in hepatic graft-versus-host-disease
|
IMMUNOLOGY LETTERS |
| Artículo | 2011 |
Limbus Damage in Ocular Graft-versus-Host Disease
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2011 |
Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial
|
HAEMATOLOGICA |
| Artículo | 2011 |
Pretransplantation Liver Function Impacts on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Study of 455 Patients
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Resumen congreso | 2011 |
Prognostic Factors for Survival and Progression to Acute Myeloid Leukemia in Patients with Lower-Risk Myelodysplastic Syndromes. A New Scoring System
|
BLOOD |
| Artículo | 2010 |
Both CD133+ cells and monocytes provide significant improvement for hindlimb ischemia, although they do not transdifferentiate into endothelial cells
|
Cell Transplantation |
| Artículo | 2010 |
Chronic graft-versus-host disease
|
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY |
| Artículo | 2010 |
Current role of allogeneic transplantation in patients with multiple myeloma: Results and recommendations in February 2010
|
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY |
| Revisión | 2010 |
European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma
|
LEUKEMIA & LYMPHOMA |
| Artículo | 2010 |
Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting
|
BLOOD |
| Revisión | 2010 |
Immunomodulatory effect of mesenchymal stem cells
|
Brazilian Journal of Medical and Biological Research |
| Revisión | 2010 |
International Myeloma Working Group Consensus Statement Regarding the Current Status of Allogeneic Stem-Cell Transplantation for Multiple Myeloma
|
JOURNAL OF CLINICAL ONCOLOGY |
| Letter | 2010 |
Liver function tests and absolute lymphocyte count at day+100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant
|
AMERICAN JOURNAL OF HEMATOLOGY |
| Artículo | 2010 |
P22(phox)-dependent NADPH oxidase activity is required for megakaryocytic differentiation
|
CELL DEATH AND DIFFERENTIATION |
| Artículo | 2009 |
Alemtuzumab as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II Study
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Ponencia | 2009 |
Allogenic stem cell transplant in MDS: results of the Spanish registry
|
LEUKEMIA RESEARCH |
| Artículo | 2009 |
Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q-syndrome
|
LEUKEMIA |
| Artículo | 2009 |
Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy
|
TRANSFUSION |
| Artículo | 2009 |
Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura
|
CYTOTHERAPY |
| Artículo | 2009 |
Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies
|
AMERICAN JOURNAL OF HEMATOLOGY |
| Artículo | 2009 |
Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Chronic Graft-versus-Host Disease
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2009 |
Treatment with bortezomib of human CD4(+) T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population
|
HAEMATOLOGICA |
| Artículo | 2008 |
A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma
|
BLOOD |
| Artículo | 2008 |
Beclometasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease.
|
EXPERT OPINION ON INVESTIGATIONAL DRUGS |
| Artículo | 2008 |
Clinical and Prognostic Value of Discrepancies in Microsatellite DNA Regions Between Recipient and Donor in Human Leukocyte Antigen-Identical Allogeneic Transplantation Setting
|
TRANSPLANTATION |
| Artículo | 2008 |
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation
|
HAEMATOLOGICA |
| Corrección | 2008 |
Erratum: "Beclometasone dipropionate: A topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease" (Expert Opinion on Investigational Drugs (2008) vol. 17(9) (1389-1401))
|
Expert Opinion on Investigational Drugs |
| Artículo | 2008 |
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma
|
LEUKEMIA |
| Corrección | 2008 |
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma (vol 22, pg 1250, 2008)
|
LEUKEMIA |
| Revisión | 2008 |
Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool
|
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE |
| Artículo | 2008 |
Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: The national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2008 |
Prognostic impact of pre-transplantation computed tomography and (67)gallium scanning in chemosensitive diffuse large B cell lymphoma patients undergoing hematopoietic stem-cell transplantation
|
ANNALS OF NUCLEAR MEDICINE |
| Artículo | 2008 |
Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients
|
TRANSFUSION |
| Artículo | 2008 |
Reduced-intensity conditioning allogeneic transplantation from unrelated donors: Evaluation of mycophenolate mofetil plus cyclosporin a as graft-versus-host disease prophylaxis
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2008 |
Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: Chronic graft-versus-host disease is the strongest factor improving survival
|
JOURNAL OF CLINICAL ONCOLOGY |
| Artículo | 2008 |
The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes
|
HAEMATOLOGICA |
| Artículo | 2007 |
In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression
|
TRANSFUSION AND APHERESIS SCIENCE |
| Artículo | 2007 |
Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcome
|
HAEMATOLOGICA |
| Artículo | 2007 |
Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers
|
CYTOTHERAPY |
| Artículo | 2007 |
Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Letter | 2007 |
Use of bortezomib in the management of chronic graft-versus-host disease among multiple myeloma patients relapsing after allogeneic transplantation
|
HAEMATOLOGICA |
| Letter | 2006 |
Bone marrow mesenchymal stem cells chimerism after allogeneic hematopoietic transplantation
|
EXPERIMENTAL HEMATOLOGY |
| Artículo | 2006 |
Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines
|
BLOOD |
| Revisión | 2006 |
Chronic graft-versus-host disease: Pathogenesis and clinical management
|
DRUGS |
| Artículo | 2006 |
Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation
|
LEUKEMIA & LYMPHOMA |
| Artículo | 2006 |
G-CSF increases the number of peripheral blood dendritic cells CD16+and modifies the expression of the costimulatory molecule CD86+
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2006 |
Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD)
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2006 |
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2006 |
Prognostic impact of pretransplantation computed tomography and gallium scans in patients with Hodgkin lymphoma with poor prognosis undergoing hematopoietic stem cell transplantation
|
CLINICAL LYMPHOMA & MYELOMA |
| Letter | 2006 |
Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients
|
LEUKEMIA |
| Letter | 2006 |
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma
|
BLOOD |
| Capítulo | 2006 |
Trasplante de progenitores hematopoyéticos
|
Trasplante de órganos y células : dimensiones éticas regulatorias |
| Letter | 2006 |
Vincristine is an effective therapeutic approach for transplantation-associated thrombotic microangiopathy
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2005 |
CD34+cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
|
LEUKEMIA & LYMPHOMA |
| Artículo | 2005 |
Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma
|
HAEMATOLOGICA |
| Artículo | 2005 |
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation
|
BRITISH JOURNAL OF HAEMATOLOGY |
| Artículo | 2005 |
Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors
|
HAEMATOLOGICA |
| Artículo | 2005 |
Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: A comparison with their respective sibling donors
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2005 |
Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability
|
EXPERIMENTAL HEMATOLOGY |
| Resumen congreso | 2005 |
Rapamycine (Sirolimus) as salvage therapy for chronic graft-versus-host disease
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2005 |
Reduced-intensity conditioning stem cell transplantation with allogeneic blood fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2004 |
Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2004 |
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience
|
ANNALS OF ONCOLOGY |
| Artículo | 2004 |
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation
|
BLOOD |
| Artículo | 2004 |
Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2004 |
Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2004 |
Graft vs. host disease and graft vs. myeloma effect after non-myeloablative allogeneic transplantation
|
LEUKEMIA & LYMPHOMA |
| Artículo | 2004 |
Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation
|
HAEMATOLOGICA |
| Letter | 2004 |
Prophylactic meropenem during neutropenia in allogeneic stem cell transplant recipients - Reply
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2004 |
Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2004 |
QUALITY OF LIFE ASSESSMENT IN PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC VS AUTOLOGOUS TRANSPLANTATION: RESULTS OF A PROSPECTIVE STUDY
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2004 |
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| Artículo | 2004 |
REPLY ON BEHALF OF THE AUTHORS.
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2004 |
RESULTS AFTER AUTOLOGOUS LYMPHOMA TRANSPLANTATION ARE NOT IMPROVED BY INCREASING THE DOSE OF ETOPOSIDE IN THE BEAM REGIMEN: A SINGLE-CENTRE SEQUENTIAL COHORT STUDY.
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2004 |
Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2003 |
Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2003 |
Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation
|
BRITISH JOURNAL OF HAEMATOLOGY |
| Artículo | 2003 |
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group
|
ANNALS OF ONCOLOGY |
| Artículo | 2003 |
Impact of CD34(+) cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
|
BLOOD |
| Artículo | 2002 |
Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation
|
LEUKEMIA |
| Artículo | 2002 |
Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes
|
BLOOD |
| Artículo | 2002 |
Influence of the different CD34(+) and CD34(-) cell subsets infused on clinical outcome after non-myeloablative allogeneic peripheral blood transplantation from human leucocyte antigen-identical sibling donors
|
BRITISH JOURNAL OF HAEMATOLOGY |
| Letter | 2002 |
Intensive monitoring program for oral food intake in patients undergoing allogeneic hematopoietic cell transplantation: A cost-benefit analysis
|
NUTRITION |
| Artículo | 2002 |
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders
|
BLOOD |
| Artículo | 2002 |
The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen
|
TRANSFUSION |
| Artículo | 2001 |
Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study
|
BRITISH JOURNAL OF HAEMATOLOGY |
| Editorial | 2001 |
Debate round-table: Comments concerning chimerism studies
|
LEUKEMIA |
| Artículo | 2001 |
Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease
|
BRITISH JOURNAL OF HAEMATOLOGY |
| Artículo | 2001 |
Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2001 |
Vía clínica para el GRD 803:: trasplante alogenico de médula ósea (período de trasplante).
|
Enfermería Oncológica |
| Artículo | 2000 |
ARE MYELOMA PATIENTS WITH RENAL FAILURE CANDIDATES FOR AUTOLOGOUS STEM CELL TRANSPLANTATION?
|
Hematology Journal |
| Artículo | 2000 |
Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic stem cell transplantation
|
BONE MARROW TRANSPLANTATION |
| Artículo | 2000 |
Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation
|
BONE MARROW TRANSPLANTATION |
| Artículo | 1999 |
Clinical significance of CD34(+) cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation
|
BONE MARROW TRANSPLANTATION |
| Artículo | 1999 |
Correlation of rhodamine 123 efflux by neoplastic plasma cells with clinical and biological characteristics of multiple myeloma
|
CYTOMETRY |
| Artículo | 1999 |
Neurological complications after autologous stem cell transplantation
|
EUROPEAN NEUROLOGY |
| Artículo | 1999 |
Primary plasma cell leukemia: Clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics
|
BLOOD |
| Artículo | 1999 |
Proportion of S-phase tumor cells measured by flow cytometry is an independent prognostic factor in meningioma tumors
|
CYTOMETRY |
| Artículo | 1998 |
Comparison between a lyse-and-then-wash method and a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells
|
CYTOMETRY |
| Revisión | 1998 |
Fulminant angiopathy caused by allogenic transplantation of bone marrow with cerebral involvement: clinico-pathologic correlation
|
ANALES DE MEDICINA INTERNA |
| Artículo | 1998 |
Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation
|
TRANSFUSION |
| Artículo | 1998 |
Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes
|
BLOOD |
| Artículo | 1997 |
Complete cytogenetic but not molecular remission in a patient with myeloid blast crisis of chronic myeloid leukemia treated with carboplatin and ARA-C
|
HAEMATOLOGICA |
| Artículo | 1997 |
Functional expression of MDR-1 in acute myeloid leukemia: correlation with the clinical-biological, immunophenotypical, and prognostic disease characteristics
|
ANNALS OF HEMATOLOGY |
| Letter | 1997 |
Lymph node myeloid metaplasia associated with chronic neutrophilic leukemia
|
HAEMATOLOGICA |
| Letter | 1997 |
Lymph node myeloid metaplasia associated with chronic neutrophilic leukemia.
|
HAEMATOLOGICA |
| Artículo | 1997 |
Minimal number of circulating CD34+ cells to assure successful leukapheresis and engraftment in peripheral blood progenitor cell transplantation
|
Infusionstherapie und Transfusionsmedizin |
| Artículo | 1997 |
Trasplante autólogo con esquema BEAM en linfoma
|
SANGRE |
| Artículo | 1996 |
Incidence of chromosome numerical changes in multiple myeloma: Fluorescence in situ hybridization analysis using 15 chromosome-specific probes
|
AMERICAN JOURNAL OF PATHOLOGY |
| Revisión | 1996 |
Management of multiple myeloma (I): Role of chemotherapy, interferon and support therapy
|
Inflamacion y Regulacion del Crecimiento Celular |
| Revisión | 1996 |
Management of multiple myeloma (II): Allogenic and autologous bone marrow transplantation
|
Inflamacion y Regulacion del Crecimiento Celular |
